Cutaneous Manifestations in HTLV-I Positive Blood Donors

Authors

  • Amir Reza Khalighi Department of Internal Medicine ,Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Farahnaz Tehranian Research Centre of Iranian Blood Transfusion Organization, Khorasan Razavi, Mashhad, Iran
  • Fatemeh Livani Cutaneous Leishmanaisis Research Center, Department of Dermatology,School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Mahmoud Reza Azarpazhooh Department of Neurology, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Majid Shahabi Research Centre of Iranian Blood Transfusion Organization, Khorasan Razavi, Mashhad, Iran
  • Masoud Maleki Cutaneous Leishmanaisis Research Center, Department of Dermatology,School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Mohammad Esmaeil Khayami Research Centre of Iranian Blood Transfusion Organization, Khorasan Razavi, Mashhad, Iran
  • Mohammad Javad Yazdanpanah Cutaneous Leishmanaisis Research Center, Department of Dermatology,School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Mohammad Khajedaluee Department of Social Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Nasaibe Joneidi Cutaneous Leishmanaisis Research Center, Department of Dermatology,School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:

This article doesn't have abstract

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Prevalence study of neurologic manifestations in HTLV-I positive blood donors

The human T-lymphotropic virus type I (HTLV-I) is the etiologic agent of tropical spastic paraparesis / HTLV-I associated myelopathy (TSP/HAM), adult T cell leukemia/lymphoma (ATLL) as well as of other immunomediated systemic diseases. Contrary to other pathogenic viruses to man HTLV-I apparently causes diseases in the minority of the infected population. The real prevalence of HTLV-I neurologi...

full text

Anti-HTLV-I/II Seroprevalence in Healthy Blood Donors in İzmir, Turkey.

Human T-cell lymphotropic virus type I (HTLV-I) is the first human retrovirus to be associated with malignant disease-namely, adult T-cell leukemia/lymphoma. HTLV-I has also been associated with several diseases. HTLV-I has a worldwide distribution with major endemic foci in the Caribbean and Southern Japan. HTLV-II is a closely related retrovirus that shares considerable genomic homology with ...

full text

A Systematic Review for Estimation of HTLV-I Infection in the Blood Donors of Iran

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective: High prevalence of human T-cell lymphotropic virus type 1 (HTLV-I) infection in the northeastern of Iran has been proven. However, there is no overall estimation of the infection in the country. This systematic review was conducted to make an accurate estimation...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 16  issue 3

pages  273- 277

publication date 2013-03-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023